Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α-induced human vascular smooth muscle proliferation

Circulation Research

Volumn 84, Issue 8, 1999, Pages 867-875

  Selzman, Craig H ^a   Shames, Brian D ^a   Reznikov, Leonid L ^a   Miller, Stephanie A ^a   Meng, Xianzhong ^a   Barton, Hazel A ^a   Werman, Ariel ^a   Harken, Alden H ^a   Dinarello, Charles A ^a   Banerjee, Anirban ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cationic liposome; Inhibitory B ; Nuclear factor B; Tumor necrosis factor; Vascular smooth muscle

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; CELL CULTURE; CELL PROLIFERATION; CYTOKINE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; VASCULAR SMOOTH MUSCLE;

EID: 0033617360     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.8.867     Document Type: Article

References (39)

1. Barath P, Fishbein BC, Cao H, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
2. Warner SJC, Libby P. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol. 1989;142:100-109.
3. Chen XL, Tummala PE, Olliff L, Medford RM. E-selectin gene expression in vascular smooth muscle cells. Circ Res. 1997;80:305-311.
4. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol. 1997;17:490-497.
5. Morisake N, Xu QP, Koshikawa T, Saito Y, Yoshida S, Ueda S. Tumour necrosis factor-α can modulate the phenotype of aortic smooth muscle cells. Scand J Clin Lab Invest. 1993;53:347-352.
6. Geng YJ, Qi MM, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α and interleukin 1β. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
7. Steeme S, Jonasson L, Holm J, Hansson GK. Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis. Transplant Proc. 1989;4:3697-3699.
8. Sawada H, Kan M, McKeehan WL. Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells. In Vitro Cell Dev Biol. 1990;26:213-216.
9. Bourcier T, Sukhova G, Libby P. The nuclear factor κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997;272:15817-15824.
10. Siebenlist U, Franzoso G, Brown K. Structure, regulation, and function of NF-κB. Annu Rev Cell Biol. 1994;10:405-455.
11. Lawrence R, Chang LJ, Siebenlist U, Bressler P, Sonenshien GE. Vascular smooth muscle cells express a constitutive NF-κB like activity. J Biol Chem. 1994;269:28913-28918.
12. Bellas RE, Lee JS, Sonenshein GE. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest. 1995;96:2521-2527.
13. Bretschneider E, Wieepoth M, Weber AA, Glusa E, Schror K. Activation of NFκB is essential but not sufficient to stimulate mitogenesis of vascular smooth muscle cells. Biochem Biophys Res Commun. 1997;235: 365-368.
14. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95, and IL-1. Nature. 1997;385:540-544.
15. Sun SC, Ganchi PA, Ballard SW, Greene WC. NF-κB controls expression of inhibitor IκBa: evidence for an inducible autoregulatory pathway. Science. 1993;259:1912-1915.
16. Zabel U, Baeuerle PA. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell. 1990;61:255-265.
17. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C. Nuclear localization of IκBa promotes active transport of NF-κB from the nucleus to the cytoplasm. J Cell Science. 1997;110:369-378.
18. Selzman CH, McIntyre R Jr, Shames BD, Whitehill TA, Banerjee A, Harken AH. Interleukin-10 inhibits human vascular smooth muscle proliferation. J Mol Cell Cardiol. 1998;30:889-896.
19. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991;3:207-212.
20. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989;140:323-334.
21. Margulis RA, Sandler S, Eizirik DL, Welsh N, Welsh M. Liposomal delivery of purified hsp 70 into rat pancreatic islets as protection against interleukin-1β impaired β-cell function. Diabetes. 1991;40:1418-1422.
22. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, Meng X. Increased levels of myocardial IκB-α protein promote tolerance to endotoxin. Am J Physiol. 1998;275:H1084-H1091.
23. Puren AJ, Fantuzzi G, Gu Y, Su M, Dinarello CA. Interleukin-18 (IFN-inducing factor) induces IL-8 and IL-1 via TNF production from non-CD14+ human blood mononuclear cells. J Clin Invest. 1998;101: 711-721.
24. Lin YC, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci USA. 1995;92: 552-556.
25. Sheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283-286.
26. Chaturvedi MM, Higuchi M, Aggarwal BB. Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-κB: evidence for lack of correlation with cell proliferation. Lymphokine Cytokine Res. 1994;13:309-313.
27. O'Connell MA, Cleere R, Long A, O'Neill LAJ, Kelleher D. Cellular proliferation and activation of NF-κB are induced by autocrine production of tumor necrosis factor α in the human T lymphoma line HuT 78. J Biol Chem. 1995;270:7399-7404.
28. Hsu H, Sju HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299-308.
29. Yang Z, Costanzo M, Golde DW, Kolesnick RN. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J Biol Chem. 1993;268:20520-20523.
30. Beg A, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 1996;274:782-784.
31. Baldwin AS. The NF-κB, and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-681.
32. Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int. 1990;20:445-454.
33. Bequparlant P, Hiscott J. Biologic and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev. 1996;7:175-190.
34. Scott-Burden T, Engler DA, Tock CL, Schwartz JJ, Casscells SW. Liposomal induction of NO synthase expression in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1997;231:780-783.
35. Pickering JG, Lekanowcki J, Weir L, Takeshita S, Losordo DW, Isner JM. Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation. 1994;89:13-21.
36. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription. J Biol Chem. 1998;273:6607-6610.
37. Imbert V, Rupee RA, Libolsi A, Pahl HL, Traenckner EBM, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JR. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell. 1996;86:787-798.
38. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tram N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue. Circ Res. 1993;73: 223-231.
39. Libby P. Molecular bases of the acute coronary syndrome. Circulation. 1995;91:2844-2850.